TREM2 and Alzheimer disease: Proitsi et al. report that lipidomic network analysis of post-mortem brain tissue reveals increased levels of phospholipids and sphingomyelins in Alzheimer’s disease brain donors, especially in carriers of rare TREM2 risk variants.